Journal of Surgical Research
Volume 140, Issue 1 , Pages 50-54 , 1 June 2007

Adenoviral Serotypes in Gene Therapy for Esophageal Carcinoma

Received 26 July 2006

References 

  1. Gomez-Navarro J, Curiel DT, Douglas JT. Gene therapy for cancer. Eur J Cancer. 1999;35:2039
  2. Kanerva A, Hemminki A. Modified adenoviruses for cancer gene therapy. Int J Cancer. 2004;110:475
  3. Rots MG, Curiel DT, Gerritsen WR, et al. Targeted cancer gene therapy: The flexibility of adenoviral gene therapy vectors. J Control Release. 2003;87:159
  4. Wadell G. Molecular epidemiology of human adenoviruses. Curr Top Microbiol Immunol. 1984;110:191
  5. Bergelson JM. Receptors mediating adenovirus attachment and internalization. Biochem Pharmacol. 1999;57:975
  6. Goossens PH, Vogels R, Pieterman E, et al. The influence of synovial fluid on adenovirus-mediated gene transfer to the synovial tissue. Arthritis Rheum. 2001;44:48
  7. Yotnda P, Onishi H, Heslop HE, et al. Efficient infection of primitive hematopoietic stem cells by modified adenovirus. Gene Ther. 2001;8:930
  8. Havenga MJ, Lemckert AA, Ophorst OJ, et al. Exploiting the natural diversity in adenovirus tropism for therapy and prevention of disease. J Virol. 2002;76:4612
  9. Rea D, Havenga MJ, van Den AM, et al. Highly efficient transduction of human monocyte-derived dendritic cells with subgroup B fiber-modified adenovirus vectors enhances transgene-encoded antigen presentation to cytotoxic T cells. J Immunol. 2001;166:5236
  10. Havenga MJ, Lemckert AA, Grimbergen JM, et al. Improved adenovirus vectors for infection of cardiovascular tissues. J Virol. 2001;75:3335
  11. Hehir KM, Armentano D, Cardoza LM, et al. Molecular characterization of replication-competent variants of adenovirus vectors and genome modifications to prevent their occurrence. J Virol. 1996;70:8459
  12. Shabram PW, Giroux DD, Goudreau AM, et al. Analytical anion-exchange HPLC of recombinant type-5 adenoviral particles. Hum Gene Ther. 1997;8:453
  13. Nishihira T, Kasai M, Mori S, et al. Characteristics of two cell lines (TE-1 and TE-2) derived from human squamous cell carcinoma of the esophagus. Gann. 1979;70:575
  14. Rockett JC, Larkin K, Darnton SJ, et al. Five newly established esophageal carcinoma cell lines: Phenotypic and immunological characterization. Br J Cancer. 1997;75:258
  15. Wesseling JG, Bosma PJ, Krasnykh V, et al. Improved gene transfer efficiency to primary and established human pancreatic carcinoma target cells via epidermal growth factor receptor and integrin-targeted adenoviral vectors. Gene Ther. 2001;8:969
  16. Hierholzer JC. Further subgrouping of the human adenoviruses by differential hemagglutination. J Infect Dis. 1973;128:541
  17. Wadell G. Classification of human adenoviruses by SDS-polyacrylamide gel electrophoresis of structural polypeptides. Intervirology. 1979;11:47
  18. Bailey A, Mautner V. Phylogenetic relationships among adenovirus serotypes. Virology. 1994;205:438
  19. Uhnoo I, Wadell G, Svensson L, et al. Importance of enteric adenoviruses 40 and 41 in acute gastroenteritis in infants and young children. J Clin Microbiol. 1984;20:365
  20. De Jong JC, Wermenbol AG, Verweij-Uijterwaal MW, et al. Adenoviruses from human immunodeficiency virus-infected individuals, including two strains that represent new candidate serotypes Ad50 and Ad51 of species B1 and D, respectively. J Clin Microbiol. 1999;37:3940
  21. Rice TW, Falk GW, Achkar E, et al. Surgical management of high-grade dysplasia in Barrett’s esophagus. Am J Gastroenterol. 1993;88:1832
  22. Gaggar A, Shayakhmetov DM, Lieber A. CD46 is a cellular receptor for group B adenoviruses. Nat Med. 2003;9:1408
  23. Ni S, Gaggar A, Di Paolo N, et al. Evaluation of adenovirus vectors containing serotype 35 fibers for tumor targeting. Cancer Gene Ther. 2006;

PII: S0022-4804(06)00623-8

doi: 10.1016/j.jss.2006.12.006

Journal of Surgical Research
Volume 140, Issue 1 , Pages 50-54 , 1 June 2007

Article Tools

* Image Usage & Resolution